Nanoparticle display of prefusion coronavirus spike elicits S1-focused cross-reactive protection across divergent subgroups

Abstract Multivalent antigen display is a fast-growing area of interest towards broadly protective vaccines. Current nanoparticle-based vaccine candidates demonstrate the ability to confer antibody-mediated immunity against divergent strains of notably mutable viruses. In coronaviruses, this work is predominantly aimed at targeting conserved epitopes of the receptor-binding domain. However, targeting other conserved non-RBD epitopes could further limit the potential for antigenic escape. To further explore new potential targets, we engineered protein nanoparticles displaying CoV_S-2P trimers derived from MERS-CoV, SARS-CoV-1, SARS-CoV-2, hCoV-HKU1, and hCoV-OC43 and assessed their immunogenicity in mice. Monotypic SARS-1_S-2P nanoparticles elicited cross-neutralizing antibodies against MERS_S and protected against MERS-CoV challenge. MERS and SARS-I53_dn5 nanoparticles elicited S1-focused antibodies, revealing a conserved site on the NTD. Moreover, mosaic nanoparticles co-displaying distinct CoV_S-2P trimers elicited antibody responses to distant cross-group antigens while protecting against MERS challenge despite diminished valency of MERS_S-2P. Our findings will inform further efforts towards the development of pan-coronavirus vaccines.

[1]  B. Pulendran,et al.  Distinct sensitivities to SARS-CoV-2 variants in vaccinated humans and mice , 2022, bioRxiv.

[2]  R. Baric,et al.  Stabilized coronavirus spike stem elicits a broadly protective antibody , 2021, Cell Reports.

[3]  L. Vaca,et al.  SARS-CoV-2 Vaccines Based on the Spike Glycoprotein and Implications of New Viral Variants , 2021, Frontiers in Immunology.

[4]  B. Pulendran,et al.  Elicitation of broadly protective sarbecovirus immunity by receptor-binding domain nanoparticle vaccines , 2021, bioRxiv.

[5]  D. Baker,et al.  Quadrivalent influenza nanoparticle vaccines induce broad protection , 2021, Nature.

[6]  D. Weissman,et al.  Chimeric spike mRNA vaccines protect against Sarbecovirus challenge in mice , 2021, Science.

[7]  M. Davenport,et al.  Protective neutralization titre for COVID-19 , 2021 .

[8]  M. Nussenzweig,et al.  Mosaic nanoparticles elicit cross-reactive immune responses to zoonotic coronaviruses in mice , 2020, Science.

[9]  Z. Memish,et al.  Human Coronavirus Infections—Severe Acute Respiratory Syndrome (SARS), Middle East Respiratory Syndrome (MERS), and SARS-CoV-2 , 2020, Reference Module in Biomedical Sciences.

[10]  Yunwei Lou,et al.  The SARS-CoV-2 Spike Glycoprotein Biosynthesis, Structure, Function, and Antigenicity: Implications for the Design of Spike-Based Vaccine Immunogens , 2020, Frontiers in Immunology.

[11]  D. Burton,et al.  Cross-reactive serum and memory B cell responses to spike protein in SARS-CoV-2 and endemic coronavirus infection , 2020, bioRxiv.

[12]  Shuwen Liu,et al.  Structural and functional properties of SARS-CoV-2 spike protein: potential antivirus drug development for COVID-19 , 2020, Acta Pharmacologica Sinica.

[13]  Nicholas C. Wu,et al.  Cross-reactive antibody response between SARS-CoV-2 and SARS-CoV infections , 2020, bioRxiv.

[14]  D. Baker,et al.  Structural and functional evaluation of de novo-designed, two-component nanoparticle carriers for HIV Env trimer immunogens , 2020, bioRxiv.

[15]  D. Baker,et al.  Tailored design of protein nanoparticle scaffolds for multivalent presentation of viral glycoprotein antigens , 2020, bioRxiv.

[16]  Barney S. Graham,et al.  Structural Definition of a Neutralization-Sensitive Epitope on the MERS-CoV S1-NTD , 2019, Cell Reports.

[17]  D. Baker,et al.  Enhancing and shaping the immunogenicity of native-like HIV-1 envelope trimers with a two-component protein nanoparticle , 2019, Nature Communications.

[18]  U. Baxa,et al.  Mosaic nanoparticle display of diverse influenza virus hemagglutinins elicits broad B cell responses , 2018, Nature Immunology.

[19]  Zhènglì Shí,et al.  Origin and evolution of pathogenic coronaviruses , 2018, Nature Reviews Microbiology.

[20]  V. Corman,et al.  Hosts and Sources of Endemic Human Coronaviruses , 2018, Advances in Virus Research.

[21]  R. Baric,et al.  Adaptive evolution influences the infectious dose of MERS-CoV necessary to achieve severe respiratory disease , 2017, Virology.

[22]  Barney S. Graham,et al.  Immunogenicity and structures of a rationally designed prefusion MERS-CoV spike antigen , 2017, Proceedings of the National Academy of Sciences.

[23]  R. Baric,et al.  A mouse model for MERS coronavirus-induced acute respiratory distress syndrome , 2016, Nature Microbiology.

[24]  Barney S. Graham,et al.  Pre-fusion structure of a human coronavirus spike protein , 2016, Nature.

[25]  Sjors H.W. Scheres,et al.  RELION: Implementation of a Bayesian approach to cryo-EM structure determination , 2012, Journal of structural biology.

[26]  Wen Jiang,et al.  EMAN2: an extensible image processing suite for electron microscopy. , 2007, Journal of structural biology.

[27]  David N Mastronarde,et al.  Automated electron microscope tomography using robust prediction of specimen movements. , 2005, Journal of structural biology.

[28]  Shibo Jiang,et al.  Receptor-binding domain of SARS-CoV spike protein induces highly potent neutralizing antibodies: implication for developing subunit vaccine , 2004, Biochemical and Biophysical Research Communications.

[29]  A Leith,et al.  SPIDER and WEB: processing and visualization of images in 3D electron microscopy and related fields. , 1996, Journal of structural biology.